A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease.
- 1 April 2005
- journal article
- research article
- Published by Emerald
- Vol. 40 (2), 577-91
- https://doi.org/10.1111/j.1475-6773.2005.00373.x
Abstract
On the eight scales of the Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36), Version 2, we compared the clinically important difference (CID) thresholds for change over time developed by three separate expert panels of physicians with experience in quality of life assessment among patients with chronic obstructive pulmonary disease (COPD), asthma, and heart disease. We used a modified Delphi technique combined with a face-to-face panel meeting within each disease to organize and conduct the consensus process among the expert panelists, who were familiar with the assessment and evaluations of health-related quality of life (HRQL) measures among patients with the panel-specific disease. Each of the expert panels first determined the magnitude of the smallest numerically possible change on each SF-36 scale, referred to as a state change, and then built their CIDs from this metric. All three panels attained consensus on the scale changes that constituted small, moderate, and large clinically important SF-36 change scores. The CIDs established by the heart disease panel were generally greater than the CIDs agreed on by the asthma and COPD panels. These panel-derived thresholds reflect possible differences in disease management among the represented panel-specific diseases, and are all greater than the minimal CID thresholds previously developed for the SF-36 scales among patients with arthritis. If confirmed among patients with the relevant diseases and those patients' physicians, these disease-specific CIDs could assist both researchers and practicing clinicians in the use and interpretation of HRQL changes over time.This publication has 23 references indexed in Scilit:
- The Clinical Significance of Quality-of-Life Results: Practical Considerations for Specific AudiencesMayo Clinic Proceedings, 2002
- Individual Differences in Quality-of-Life Treatment ResponseMedical Care, 2002
- Methods to Explain the Clinical Significance of Health Status MeasuresMayo Clinic Proceedings, 2002
- Assessing Clinical Significance in Measuring Oncology Patient Quality of Life: Introduction to the Symposium, Content Overview, and Definition of TermsMayo Clinic Proceedings, 2002
- Using the standard error of measurement to identify important changes on the Asthma Quality of Life QuestionnaireQuality of Life Research, 2002
- Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritisArthritis & Rheumatism, 2000
- Further Evidence Supporting an SEM-Based Criterion for Identifying Meaningful Intra-Individual Changes in Health-Related Quality of LifeJournal of Clinical Epidemiology, 1999
- Linking Clinical Relevance and Statistical significance in Evaluating Intra-Individual Changes in Health-Related Quality of LifeMedical Care, 1999
- Generic versus Disease-Specific Health Status MeasuresEvaluation & the Health Professions, 1998
- The Reproducibility of a Method to Identify the Overuse and Underuse of Medical ProceduresNew England Journal of Medicine, 1998